F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to maintain medical records that were complete and
accurately documented for 1 (Resident #1) of 6 residents reviewed for accurate charting.
The facility failed to ensure nursing staff accurately documented controlled substance administration for
Resident #1.
This failure placed residents at risk of receiving incorrect dosages of prescribed medication.
Findings included:
Review of Resident #1's admission record revealed the resident was a [AGE] year-old male admitted to the
facility on [DATE] with diagnoses that included: major depressive disorder (mood disorder), panic disorder,
muscle spasms, and paraplegia (paralysis of legs).
Review of Resident #1's quarterly MDS assessment, dated 03/29/23, revealed Resident #1 had a BIMS
score of 15, which indicated he was cognitively intact. His Functional Status revealed he required limited or
extensive assistance with most of his ADLs.
Review of Resident #1's care plan, dated 01/31/23, revealed Resident #1 used a mood
stabilizer/anticonvulsant medication related to unspecified convulsions.
Record review of Resident #1's order summary, dated 04/27/23, revealed he had an order to receive 1
tablet of Clonazepam 1 mg three times a day for anxiety.
Record review of Resident #1's Controlled Substance Record (CSR), supplied from the pharmacy at time of
delivery, revealed Resident #1 had 20 Clonazepam 1 mg on 05/14/23, and MA B signed off for doses #1
and #2 on 05/15/23; indicating that she only administered 2 tablets of Clonazepam 1 mg on that date. MA B
did not document the balance of tablets remaining after neither dose administered. She only documented
the date, time, and her signature.
Record review of Resident #1's CSR, recreated by the DON, revealed Resident #1 had 20 Clonazepam 1
mg on 05/14/23. The DON signed off on one wasted dose on 05/14/23 and printed MA B's name for the first
three doses on 05/15/23, indicating that MA B had administered 3 tablets of Clonazepam 1 mg on that
date, with 17 tablets remaining.
Record review of Resident #1's May 2023 MAR revealed Resident #1 received:
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
676480
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676480
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mesquite Village Wellness & Rehabilitation
825 W. Kearney Street
Mesquite, TX 75149
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
3 doses of Clonazepam 1 mg at 9:00 AM, 3:00 PM, and 9:00 PM on 05/15/23, signed off with initials of a
staff who was not identified; however, it was not the initials of MA B.
Interview on 05/30/23 at 9:50 AM, MA B stated she worked at the facility through an agency and 05/15/23
was her first day ever working there. She stated she was not properly oriented to the facility when she
arrived. However, she had knowledge on administering medications, including controlled substances,
through her education, trainings, and experience. MA B stated she was given a login to access the system
and a key to the medication cart. She stated that she did not count the controlled medications with the
off-going nurse and was unsure of how many medications were in the cart before taking over. MA B stated
a nurse was taking her key throughout the shift and going in her medication cart. She stated she knew it
was not good practice to hand off her key. However, she was new at the facility and did not want to cause
problems with the staff. MA B stated she administered 2 doses of Clonazepam to Resident #1 during her
shift, at 8:00 AM and 8:00 PM. She stated she was aware that Resident #1 was ordered to receive 3 doses.
However, she did not have her key for the afternoon dose and was informed that the medication had been
administered. MA B stated she signed off on the CSR for the two doses of medication that she
administered and could not recall if she documented the remaining balance of medication. She stated her
shift ended at 10:00 PM, and while counting the medications they found that there were missing controlled
mediations for Resident #1. She could not recall how many medications were missing.
Interview on 05/30/23 at 10:35 AM, the DON stated there was one MA scheduled to work the entire facility
on 05/15/23 with a census of about 40 residents. The DON stated agency staff completed a competency
and skills check-off before being scheduled for a shift, and they were aware of the expectations before their
shift. The DON stated once the medication cart key was handed off to the MA or nurse, it should not be
shared between staff. She stated administration of controlled substances should be documented in the
MAR and on the CSR to ensure accuracy and prevent medication errors. The DON stated she was
informed at approximately 11:00 PM on 05/15/23 that the CSR and medication count did not add up. She
stated when she arrived on the morning of 05/16/23, she and LVN A investigated and found that there were
no missing medications. The DON stated MA B had filled out the CSR incorrectly, which caused the count
to be off. She stated MA B had only signed off for administering 2 doses when 3 doses were given. The
DON stated she created a new CSR and added the additional dose, which indicated that the Clonazepam 1
mg was administered three times on 05/15/23 as it was ordered, and that corrected the count. The DON
stated she later realized that she should not have created a new CSR to add the additional dose herself,
and that she should have had the staff who administered the medication to sign for it on the original CSR
provided by the pharmacy. The DON stated the importance of accurately documenting the administration of
controlled substance was to ensure that residents received the correct dosages of medications. She stated
the risk of inaccurate documenting could be underdosing or overdosing the resident
Interview on 05/30/23 at 10:55 AM, LVN A stated he worked on 05/15/23 with MA B. He denied taking the
medication cart key during the shift or hearing about other staff taking it. LVN A stated that protocol for
taking over a medication cart was to verify the count of all narcotics before receiving the key, and once you
have the key it should not be given to anyone else until the end of shift. LVN A stated he assisted the DON
with investigating the medication error from the previous night and they found that no medications were
missing. However, the CSR was inaccurate.
Interview on 05/30/23 at 11:10 AM, Resident #1 stated he had not missed any doses of medications. He
stated that he was familiar with his medications and could tell if a dose was missed by how he felt. He
stated that he had not experienced any increased spasms or pain.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676480
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676480
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/30/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mesquite Village Wellness & Rehabilitation
825 W. Kearney Street
Mesquite, TX 75149
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the facility's current, undated policy titled Policies and Procedures for Pharmaceuticals Services,
reflected in part the following:
.Schedule Medication Inventory Sheets:
The pharmacy will send scheduled medication sign off sheets for each scheduled medication. The
scheduled inventory medication sheet should be completed for each dose administered.
.Drug Diversion:
The facility must have a system that records receipt, usage, and disposition of all controlled substances in
sufficient detail that permits for an accurate reconciliation.
.Following Medication Administration:
Following resident medication administration, facility staff should appropriately document medication
administration .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676480
If continuation sheet
Page 3 of 3